| Q39632700 | 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi |
| Q42609788 | A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. |
| Q92617804 | Animal models of colorectal peritoneal metastasis |
| Q37112963 | Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease |
| Q34992944 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study |
| Q37222795 | Emerging trends for radioimmunotherapy in solid tumors |
| Q37226204 | Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin |
| Q36387694 | Therapeutic Efficacy of Alpha-RIT Using a (213)Bi-Anti-hCD138 Antibody in a Mouse Model of Ovarian Peritoneal Carcinomatosis |
| Q37174938 | Use of antibodies and immunoconjugates for the therapy of more accessible cancers |